Masataka Nakamura Kumi Itani Kousuke Miyake Takenobu Kunieda Satoshi Kaneko Hirofumi Kusaka
10.2169/internalmedicine.56.7588
Intern Med
2017;56(2):211-214.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28090055/
Antibodies, Monoclonal, Humanized / therapeutic use Multiple Sclerosis, Relapsing-Remitting / diagnosis Natalizumab / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use Multiple Sclerosis, Relapsing-Remitting / diagnosis Natalizumab / therapeutic use Case Reports Antibodies, Monoclonal, Humanized / administration & dosage Diagnosis, Differential Female Humans Integrin alpha4 / immunology Magnetic Resonance Imaging Middle Aged Multiple Sclerosis, Relapsing-Remitting / diagnostic imaging Multiple Sclerosis, Relapsing-Remitting / drug therapy Natalizumab / administration & dosage Antibodies, Monoclonal, Humanized Natalizumab Integrin alpha4
PMC5337470
28090055
Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis
2017